Evidence 1
Activity
Activity
50% Hemolysis
Toxicity
129.2±10.21 µg/mL
Hemolytic
Cytotoxic
50% Hemolysis | 129.2±10.21 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Indolicidin analogs with broad-spectrum antimicrobial activity and low hemolytic activity | Peptides | 2020